Cargando…

Targeting lipid metabolism in the treatment of ovarian cancer

Cancer cells undergo alterations in lipid metabolism to support their high energy needs, tumorigenesis and evade an anti-tumor immune response. Alterations in fatty acid production are controlled by multiple enzymes, chiefly Acetyl CoA Carboxylase, ATP-Citrate Lyase, Fatty Acid Synthase, and Stearoy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chaudhry, Saliha, Thomas, Stefani N., Simmons Jr., Glenn E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9132258/ https://www.ncbi.nlm.nih.gov/pubmed/35634242 http://dx.doi.org/10.18632/oncotarget.28241

Ejemplares similares

Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism
por: Simmons, Glenn E., et al.
Publicado: (2015)

Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer
por: Pyragius, Carmen E., et al.
Publicado: (2013)

Targeting purine metabolism in ovarian cancer
por: Liu, Jingchun, et al.
Publicado: (2022)

Quantitative Mass Spectrometry-Based Proteomics for Biomarker Development in Ovarian Cancer
por: Ryu, Joohyun, et al.
Publicado: (2021)

New Insights into Ferroptosis Initiating Therapies (FIT) by Targeting the Rewired Lipid Metabolism in Ovarian Cancer Peritoneal Metastases
por: Zhan, Shijie, et al.
Publicado: (2022)

Targeting lipid metabolism in metastatic prostate cancer
por: Scheinberg, Tahlia, et al.
Publicado: (2023)

Targeting of lipid metabolism with a metabolic inhibitor cocktail eradicates peritoneal metastases in ovarian cancer cells
por: Chen, Rain R., et al.
Publicado: (2019)

Targeting Oncogenic Rewiring of Lipid Metabolism for Glioblastoma Treatment
por: Lee, Haksoo, et al.
Publicado: (2022)

Targeting Mitochondria for Treatment of Chemoresistant Ovarian Cancer
por: Emmings, Edith, et al.
Publicado: (2019)

The “Sweet Spot” of Targeting Tumor Metabolism in Ovarian Cancers
por: Tondo-Steele, Katelyn, et al.
Publicado: (2022)

Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer
por: Aguirre-Portolés, Cristina, et al.
Publicado: (2017)

Lipid metabolism reprogramming and its potential targets in cancer
por: Cheng, Chunming, et al.
Publicado: (2018)

Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
por: Yang, Jing, et al.
Publicado: (2020)

Targeting Lipid Peroxidation for Cancer Treatment
por: Clemente, Sofia M., et al.
Publicado: (2020)

Ovarian Cancer—Why Lipids Matter
por: Zhao, Guangyuan, et al.
Publicado: (2019)

Ovarian Cancer and Glutamine Metabolism
por: Fasoulakis, Zacharias, et al.
Publicado: (2023)

Deregulation of Lipid Metabolism: The Critical Factors in Ovarian Cancer
por: Ji, Zhaodong, et al.
Publicado: (2020)

Lipid metabolism in pancreatic cancer: emerging roles and potential targets
por: Yin, Xinpeng, et al.
Publicado: (2022)

Orchestrated Action of AMPK Activation and Combined VEGF/PD-1 Blockade with Lipid Metabolic Tunning as Multi-Target Therapeutics against Ovarian Cancers
por: Yung, Mingo M. H., et al.
Publicado: (2022)

Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
por: Roy, Debarshi, et al.
Publicado: (2014)

Lipid Metabolism and Cancer
por: Cheng, Hui, et al.
Publicado: (2022)

Lipid metabolism and cancer
por: Bian, Xueli, et al.
Publicado: (2020)

Treatment implications of natural compounds targeting lipid metabolism in nonalcoholic fatty liver disease, obesity and cancer
por: Cheng, Can, et al.
Publicado: (2019)

Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
por: Chakraborty, Prabir K., et al.
Publicado: (2015)

HSP60 Regulates Lipid Metabolism in Human Ovarian Cancer
por: Li, Na, et al.
Publicado: (2021)

Targeting Lipid Metabolic Reprogramming as Anticancer Therapeutics
por: Cha, Ji-Young, et al.
Publicado: (2016)

Targeted treatment of advanced ovarian cancer: spotlight on rucaparib
por: Pearre, Diana C, et al.
Publicado: (2018)

The Potential of Novel Lipid Agents for the Treatment of Chemotherapy-Resistant Human Epithelial Ovarian Cancer
por: Nachtigal, Mark W., et al.
Publicado: (2022)

Targeting lipid metabolism in cancer: neuroblastoma
por: Agostini, Massimiliano, et al.
Publicado: (2022)

Folate Transport and One-Carbon Metabolism in Targeted Therapies of Epithelial Ovarian Cancer
por: Wallace-Povirk, Adrianne, et al.
Publicado: (2021)

Reprogrammed Lipid Metabolism and the Lipid-Associated Hallmarks of Colorectal Cancer
por: Salita, Timothy, et al.
Publicado: (2022)

Erratum to: Loss of HSulf-1 promotes altered lipid metabolism in ovarian cancer
por: Roy, Debarshi, et al.
Publicado: (2014)

Phytochemical Targeting of STAT3 Orchestrated Lipid Metabolism in Therapy-Resistant Cancers
por: Tse, Carmen, et al.
Publicado: (2020)

How cancer cells remodel lipid metabolism: strategies targeting transcription factors
por: Jeong, Do-Won, et al.
Publicado: (2021)

Lipid Metabolism and Resistance to Anticancer Treatment
por: Germain, Nicolas, et al.
Publicado: (2020)

The ovarian reserve as target of insulin/IGF and ROS in metabolic disorder-dependent ovarian dysfunctions
por: Dri, Maria, et al.
Publicado: (2021)

Targeting Stromal-Cancer Cell Crosstalk Networks in Ovarian Cancer Treatment
por: Yeung, Tsz-Lun, et al.
Publicado: (2016)

Clinical utility of targeted treatments in the management of epithelial ovarian cancer
por: Twu, Cheryl, et al.
Publicado: (2012)

Lipid metabolism in tumor microenvironment: novel therapeutic targets
por: Liu, Xingkai, et al.
Publicado: (2022)

Current Therapeutical Approaches Targeting Lipid Metabolism in NAFLD
por: Vitulo, Manuela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1dd22sfvfepbgtembokjlmvh3o